Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Abbott acquisition of Solvay Pharmceuticals- Sep 2009


Published on

  • Be the first to comment

  • Be the first to like this

Abbott acquisition of Solvay Pharmceuticals- Sep 2009

  1. 1. Abbott’s Acquisition of Solvay Pharmaceuticals GDS_70000_Title_v1 1
  2. 2. Acquisition of Solvay Pharmaceuticals for €4.5 Billion Supports Abbott’s Long-Term Growth Strategy Abbott Strategy Solvay Brings Diversify sources of • Adds >$3B in annual long-term product revenue pharmaceuticals growth • 75% OUS revenue; 70% branded generics • Complementary product portfolio in cardiology, neuroscience and gastroenterology • Adds a growing global vaccines business and modest molecular diagnostics business Expand presence in high- • Solvay infrastructure is platform for expansion growth emerging markets • Significant presence in emerging markets, including Eastern Europe and Asia • Strong brand recognition Accelerate R&D spending to • >$500MM in incremental R&D investment capacity, adding a mix of late- and early-stage assets support long-term growth • Provides Abbott opportunity to accelerate near- and long-term pharmaceutical growth Accelerate ongoing EPS • ~$0.10 accretive to ongoing EPS in 2010 growth over the long-term • Ramping up to more than $0.20 accretion by 2012 • Ongoing EPS accretion increases after 2012 2 GDS_70000_Title_v1 2
  3. 3. Solvay Pharmaceuticals Overview Division of Solvay Group, engaged in the Overview research, manufacturing and marketing of pharmaceuticals and vaccines Headquarters Brussels, Belgium Founded 1980 Presence Active in >50 countries; products in >150 countries Major Market Cardiovascular, Neuroscience, Gastroenterology, Segments Men’s/Women’s Health and Pancreatic Enzymes 2007 Sales Product Sales Adds >$3 Billion to Abbott 3 GDS_70000_Title_v1 3
  4. 4. Solvay Pharmaceuticals Overview Geographic and Therapeutic Diversity Product Sales Product Sales by by Geography Therapeutic Area Cardiovascular United States Rest of World Men's/Women's Health Neuroscience Other Gastroenterology Pancreatic Enzymes Emerging Markets Vaccines Product Sales: Adds >$3 Billion to Abbott 4 GDS_70000_Title_v1 4